Daniel Curcio

Daniel Curcio

UNVERIFIED PROFILE

Are you Daniel Curcio?   Register this Author

Register author
Daniel Curcio

Daniel Curcio

Publications by authors named "Daniel Curcio"

Are you Daniel Curcio?   Register this Author

35Publications

445Reads

13Profile Views

Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).

Authors:
Massimo Sartelli Dieter G Weber Etienne Ruppé Matteo Bassetti Brian J Wright Luca Ansaloni Fausto Catena Federico Coccolini Fikri M Abu-Zidan Raul Coimbra Ernest E Moore Frederick A Moore Ronald V Maier Jan J De Waele Andrew W Kirkpatrick Ewen A Griffiths Christian Eckmann Adrian J Brink John E Mazuski Addison K May Rob G Sawyer Dominik Mertz Philippe Montravers Anand Kumar Jason A Roberts Jean-Louis Vincent Richard R Watkins Warren Lowman Brad Spellberg Iain J Abbott Abdulrashid Kayode Adesunkanmi Sara Al-Dahir Majdi N Al-Hasan Ferdinando Agresta Asma A Althani Shamshul Ansari Rashid Ansumana Goran Augustin Miklosh Bala Zsolt J Balogh Oussama Baraket Aneel Bhangu Marcelo A Beltrán Michael Bernhard Walter L Biffl Marja A Boermeester Stephen M Brecher Jill R Cherry-Bukowiec Otmar R Buyne Miguel A Cainzos Kelly A Cairns Adrian Camacho-Ortiz Sujith J Chandy Asri Che Jusoh Alain Chichom-Mefire Caroline Colijn Francesco Corcione Yunfeng Cui Daniel Curcio Samir Delibegovic Zaza Demetrashvili Belinda De Simone Sameer Dhingra José J Diaz Isidoro Di Carlo Angel Dillip Salomone Di Saverio Michael P Doyle Gereltuya Dorj Agron Dogjani Hervé Dupont Soumitra R Eachempati Mushira Abdulaziz Enani Valery N Egiev Mutasim M Elmangory Paula Ferrada Joseph R Fitchett Gustavo P Fraga Nathalie Guessennd Helen Giamarellou Wagih Ghnnam George Gkiokas Staphanie R Goldberg Carlos Augusto Gomes Harumi Gomi Manuel Guzmán-Blanco Mainul Haque Sonja Hansen Andreas Hecker Wolfgang R Heizmann Torsten Herzog Adrien Montcho Hodonou Suk-Kyung Hong Reinhold Kafka-Ritsch Lewis J Kaplan Garima Kapoor Aleksandar Karamarkovic Martin G Kees Jakub Kenig Ronald Kiguba Peter K Kim Yoram Kluger Vladimir Khokha Kaoru Koike Kenneth Y Y Kok Victory Kong Matthew C Knox Kenji Inaba Arda Isik Katia Iskandar Rao R Ivatury Maurizio Labbate Francesco M Labricciosa Pierre-François Laterre Rifat Latifi Jae Gil Lee Young Ran Lee Marc Leone Ari Leppaniemi Yousheng Li Stephen Y Liang Tonny Loho Marc Maegele Sydney Malama Hany E Marei Ignacio Martin-Loeches Sanjay Marwah Amos Massele Michael McFarlane Renato Bessa Melo Ionut Negoi David P Nicolau Carl Erik Nord Richard Ofori-Asenso AbdelKarim H Omari Carlos A Ordonez Mouaqit Ouadii Gerson Alves Pereira Júnior Diego Piazza Guntars Pupelis Timothy Miles Rawson Miran Rems Sandro Rizoli Claudio Rocha Boris Sakakushev Miguel Sanchez-Garcia Norio Sato Helmut A Segovia Lohse Gabriele Sganga Boonying Siribumrungwong Vishal G Shelat Kjetil Soreide Rodolfo Soto Peep Talving Jonathan V Tilsed Jean-Francois Timsit Gabriel Trueba Ngo Tat Trung Jan Ulrych Harry van Goor Andras Vereczkei Ravinder S Vohra Imtiaz Wani Waldemar Uhl Yonghong Xiao Kuo-Ching Yuan Sanoop K Zachariah Jean-Ralph Zahar Tanya L Zakrison Antonio Corcione Rita M Melotti Claudio Viscoli Perluigi Viale

World J Emerg Surg 2016 15;11:33. Epub 2016 Jul 15.

Infectious Diseases Unit, Department of Medical and Surgical Sciences, Sant' Orsola Hospital, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13017-016-0089-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946132PMC
May 2018

Comment on: Impact of pneumococcal conjugate vaccine in children morbidity and mortality in Peru: Time series analysis.

Vaccine 2017 09;35(37):4825

Medical Head Pfizer Vaccines Emerging Markets, Argentina; Medical Lead North Andes Pfizer Vaccines, Argentina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2017.03.050DOI Listing
September 2017

Redefining risk categories for pneumococcal disease in adults: critical analysis of the evidence.

Int J Infect Dis 2015 Aug 19;37:30-5. Epub 2015 May 19.

Global Pneumococcal Vaccines, Pfizer Inc., , Collegville, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijid.2015.05.003DOI Listing
August 2015

Multidrug-resistant Gram-negative bacterial infections: are you ready for the challenge?

Authors:
Daniel Curcio

Curr Clin Pharmacol 2014 Feb;9(1):27-38

Hospital Municipal Chivilcoy, Infectología Institucional SRL, Santo Tomé 5239 4 to 22, (1419) Capital Federal, Buenos Aires, Argentina.

View Article

Download full-text PDF

Source
February 2014

A comparative analysis between survivors and nonsurvivors patients treated with tigecycline.

Authors:
Daniel Curcio

Braz J Infect Dis 2013 Mar-Apr;17(2):277-8. Epub 2013 Feb 27.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bjid.2012.08.027DOI Listing
January 2014

Antibiotic prescription in intensive care units in Latin America.

Rev Argent Microbiol 2011 Jul-Sep;43(3):203-11

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1590/S0325-75412011000300007DOI Listing
May 2012

Comment on: Efficacy and safety of tigecycline: a systematic review and meta-analysis.

J Antimicrob Chemother 2011 Dec 15;66(12):2893-5; author reply 2895-6. Epub 2011 Sep 15.

View Article

Download full-text PDF

Source
https://academic.oup.com/jac/article-lookup/doi/10.1093/jac/
Publisher Site
http://dx.doi.org/10.1093/jac/dkr368DOI Listing
December 2011

Skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus: role of tigecycline.

Authors:
Daniel Curcio

Clin Infect Dis 2011 Jun 14;52(12):1468-9. Epub 2011 Apr 14.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/cir192DOI Listing
June 2011

Tigecycline for treating ventilator-associated pneumonia: a practical perspective.

Authors:
Daniel Curcio

Diagn Microbiol Infect Dis 2011 Apr;69(4):466-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.diagmicrobio.2010.11.001DOI Listing
April 2011

Tigecycline for severe infections: the gap between the warning and the necessity.

Authors:
Daniel Curcio

J Antimicrob Chemother 2011 Feb 25;66(2):454-6. Epub 2010 Nov 25.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkq454DOI Listing
February 2011

Tigecycline treatment of critically ill patients: the LatinUser experience.

Curr Clin Pharmacol 2011 Feb;6(1):18-25

Instituto Sacre Cour, Infectología Institucional SRL, Buenos Aires, Argentina.

View Article

Download full-text PDF

Source
February 2011

Activity of a novel combination against multidrug-resistant nonfermenters: ceftazidime plus NXL104.

Authors:
Daniel Curcio

Expert Rev Anti Infect Ther 2011 Feb;9(2):173-6

Instituto Sacre Cour, Infectología Institucional SRL, Buenos Aires, Argentina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/eri.10.173DOI Listing
February 2011

Resistant pathogen-associated skin and skin-structure infections: antibiotic options.

Authors:
Daniel Curcio

Expert Rev Anti Infect Ther 2010 Sep;8(9):1019-36

Instituto Sacre Cour, Infectología Institucional SRL, Buenos Aires, Argentina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/eri.10.87DOI Listing
September 2010

Antibiotic stewardship: the "real world" when resources are limited.

Authors:
Daniel Curcio

Infect Control Hosp Epidemiol 2010 Jun;31(6):666-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/653073DOI Listing
June 2010

Tigecycline in the treatment of ventilator-associated pneumonia: experience from the Latin American Tigecycline Use Registry.

Infez Med 2010 Mar;18(1):27-34

Instituto Sacre Cour, Infectologia Institucional SRL, Paraguay 3128 (1425), Buenos Aires, Argentina.

View Article

Download full-text PDF

Source
March 2010

Off-label use of antibiotics in hospitalized patients: focus on tigecycline.

Authors:
Daniel Curcio

J Antimicrob Chemother 2009 Dec 16;64(6):1344-6. Epub 2009 Sep 16.

Infectious Diseases Department, Instituto Sacre Cour, Infectología Institucional SRL, Capital Federal, Argentina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkp342DOI Listing
December 2009

Comment: tigecycline for the treatment of Acinetobacter infections: a case series.

Authors:
Daniel Curcio

Ann Pharmacother 2008 Nov 30;42(11):1717-8; author reply 1718. Epub 2008 Sep 30.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1345/aph.1L171aDOI Listing
November 2008

Rates of antimicrobial resistance in Latin America (2004-2007) and in vitro activity of the glycylcycline tigecycline and of other antibiotics.

Braz J Infect Dis 2008 Oct;12(5):405-15

Hospital das Clínicas, University of São Paulo, São Paulo, Brazil.

View Article

Download full-text PDF

Source
October 2008

Tigecycline for treating bloodstream infections: a critical analysis of the available evidence.

Authors:
Daniel Curcio

Diagn Microbiol Infect Dis 2008 Jul 14;61(3):358-9; author reply 360-1. Epub 2008 Mar 14.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.diagmicrobio.2008.01.025DOI Listing
July 2008

Indications of a new antibiotic in clinical practice: results of the tigecycline initial use registry.

Braz J Infect Dis 2008 Jun;12(3):198-201

Infectious Diseases Department, San José Hospital, Buenos Aires, Argentina.

View Article

Download full-text PDF

Source
June 2008

[Initial use of tigecycline in Argentina].

Rev Chilena Infectol 2007 Dec 13;24(6):497-9. Epub 2007 Dec 13.

Infectología Institucional SRL, Sanatorio San José, Buenos Aires, Argentina.

View Article

Download full-text PDF

Source
http://dx.doi.org//S0716-10182007000600012DOI Listing
December 2007

Acinetobacter spp. susceptibility to tigecycline: a worldwide perspective.

J Antimicrob Chemother 2007 Aug 7;60(2):449-50. Epub 2007 Jun 7.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkm202DOI Listing
August 2007